Covestro (1COV) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jul, 2026Executive summary
2025 was marked by a challenging market environment with significant pricing pressure, adverse FX impacts, and stable volumes, prompting active management and transformation initiatives.
The company continued its Sustainable Future strategy, focusing on operational excellence, customer centricity, and efficiency, while advancing partnerships and portfolio changes.
Major milestones included the partnership with XRG, acquisitions of Pontacol and Vencorex, and progress in sustainability and digitalization.
EBITDA fell 30.9% year-over-year to €740m, within guidance, as margin pressure persisted.
Net income was negative at -€644m, reflecting significantly lower EBIT and impairment losses.
Financial highlights
Sales declined by 8.7% year-over-year to €12.9bn, mainly due to a 5.2% price decline and 2.6% FX impact, while volumes remained relatively stable.
EBITDA dropped to €740m from €1.1bn in 2024, reflecting margin pressure, negative price delta, and restructuring costs.
Free operating cash flow was -€283m, with Q4 showing a positive swing due to disciplined working capital and investment management.
Investments/capex totaled €770m, in line with guidance.
Earnings per share declined to -€3.39 from -€1.41 year-over-year.
Outlook and guidance
FY 2026 EBITDA is expected to be around the 2025 level, with possible single-digit percentage deviation.
Significant year-over-year increase anticipated in free operating cash flow and ROCE over WACC.
Sustainability targets include greenhouse gas emissions (scope 1 and 2) between 3.9 and 4.5 million tons.
Mark-to-market EBITDA for FY 2026 projected at approximately €0.8bn.
Latest events from Covestro
- EBITDA surged 64.4% to €669 million as margins improved despite lower sales.1COV
Q2 2026 - AGM approved all items as company advances digital, sustainable growth amid ongoing challenges.1COV
AGM 2025 - FY 2025 saw lower sales and earnings, but transformation and climate targets remain on track.1COV
Investor presentation - EBITDA fell 30.9% to €740m as strategic actions and XRG partnership offset weak demand.1COV
Q4 2025 (Media) - Sales and EBITDA fell in Q3 2025, with guidance cut and acquisitions advancing.1COV
Q3 2025 - ADNOC's €62/share offer and €1.17bn capital boost support growth, sustainability, and governance.1COV
Investor Update - Q3 volume growth offset price declines; FY 2024 outlook narrowed amid margin pressure.1COV
Q3 2024 - Volume growth offset by lower prices; earnings and guidance down, STRONG program and ADNOC talks underway.1COV
Q2 2024 - Stable EBITDA and volume growth offset price declines; XRG takeover and STRONG program drive outlook.1COV
Q4 2024